Back to Search Start Over

Arterial Pulsatility and Circulating von Willebrand Factor in Patients on Mechanical Circulatory Support

Authors :
Nicolas Debry
Claudia Mourran
Augustin Coisne
David M. Smadja
Bart Staels
Antoine Capel
Christoph Nix
Christian Latremouille
Alexandre Ung
Cécile V. Denis
Natacha Rousse
Hugues Spillemaeker
Eric Van Belle
Cristian Preda
Alain Carpentier
Antoine Rauch
Svenja Barth
Pascal Leprince
Gilles Lemesle
Claudine Caron
André Vincentelli
Marjorie Richardson
Camille Paris
Piet Jansen
Emmanuel Robin
Annabelle Dupont
Julien Amour
Yoann Sottejeau
Peter J. Lenting
Guillaume Schurtz
Flavien Vincent
Valentin Loobuyck
Mickael Rosa
Sophie Susen
Delphine Corseaux
Cedric Delhaye
Thomas Hubert
Mouhamed Moussa
Emmanuelle Jeanpierre
Valérie Gomane
Récepteurs Nucléaires, Maladies Métaboliques et Cardiovasculaires - U1011 (RNMCD)
Institut Pasteur de Lille
Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)
CHU Lille
Hôpital Européen Georges Pompidou [APHP] (HEGP)
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)
Innovations thérapeutiques en hémostase = Innovative Therapies in Haemostasis (IThEM - U1140)
Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)
Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Research Unit on Cardiovascular and Metabolic Diseases (ICAN)
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Institut de Cardiométabolisme et Nutrition = Institute of Cardiometabolism and Nutrition [CHU Pitié Salpêtrière] (IHU ICAN)
CHU Pitié-Salpêtrière [AP-HP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-CHU Pitié-Salpêtrière [AP-HP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)
Institut de Cardiométabolisme et Nutrition = Institute of Cardiometabolism and Nutrition [CHU Pitié Salpêtrière] (IHU ICAN)
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)
Université Paris Descartes - Paris 5 (UPD5)
Université Sorbonne Paris Cité (USPC)
Carmat SA
Laboratoire Paul Painlevé (LPP)
Université de Lille-Centre National de la Recherche Scientifique (CNRS)
Recherche translationnelle sur le diabète - U 1190 (RTD)
Hémostase, Inflammation, Thrombose (HITH - U1176 Inserm - CHU Bicêtre)
Institut National de la Santé et de la Recherche Médicale (INSERM)-AP-HP Hôpital Bicêtre (Le Kremlin-Bicêtre)-Université Paris-Saclay
ANR-17-RHUS-0011,WILLASSISTHEART,New diagnostic and therapeutic solutions to cotrol bleeding complications during the use of mechanical circulatory support devices(2017)
Source :
Journal of the American College of Cardiology, Journal of the American College of Cardiology, 2018, 71 (19), pp.2106-2118. ⟨10.1016/j.jacc.2018.02.075⟩
Publication Year :
2018
Publisher :
Elsevier BV, 2018.

Abstract

International audience; Background: The main risk factor for bleeding in patients with continuous-flow mechanical circulatory support (CF-MCS) is the acquired von Willebrand factor (VWF) defect related to the high shear-stress forces developed by these devices. Although a higher bleeding rate has been reported in CF-MCS recipients who had reduced pulsatility, the relation between pulsatility and the VWF defect has never been studied.Objectives: The purpose of this study was to investigate the relation between pulsatility and VWF under CF-MCS.Methods: We assessed the effect of 2 CF-MCS on VWF multimer degradation in a mock circulatory loop (model 1). Using these devices, we investigated in a dose-effect model (model 2) 3 levels of pulsatility in 3 groups of swine. In a cross-over model (model 3), we studied the effects of sequential changes of pulsatility on VWF. We reported the evolution of VWF multimerization in a patient undergoing serial CF-MCS and/or pulsatile-MCS.Results: We demonstrated the proteolytic degradation of VWF multimers by high shear CF-MCS in a circulatory loop without pulsatility. We observed both in swine models and in a patient that the magnitude of the VWF degradation is modulated by the pulsatility level in the high shear-stress level condition, and that the restoration of pulsatility is a trigger for the endothelial release of VWF.Conclusions: We demonstrated that the VWF defect reflects the balance between degradation induced by the shear stress and the endothelial release of new VWF triggered by the pulsatility. This modulation of VWF levels could explain the relationship between pulsatility and bleeding observed in CF-MCS recipients. Preservation of pulsatility may be a new target to improve clinical outcomes of patients.

Details

ISSN :
07351097 and 15583597
Volume :
71
Database :
OpenAIRE
Journal :
Journal of the American College of Cardiology
Accession number :
edsair.doi.dedup.....2ec6e50421e10e74b680af3452d861b3
Full Text :
https://doi.org/10.1016/j.jacc.2018.02.075